Equity Medical, LLC

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials
• Hidradenitis suppurativa2 trials
• Melanoma1 trial

Phase

• Phase 33 trials
• Phase 11 trial
• Phase 21 trial

Status

• Active, not recruiting3 trials
• Recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Celldex Therapeutics1 trial
• Incyte Corporation1 trial
• Novartis Pharmaceuticals1 trial
• Organon and Co1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

  NCT07265479· Phase 3· Organon and Co· Source

• Recruiting

  Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

  NCT07049575· Phase 1· Incyte Corporation· Source

• Active, not recruiting

  A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)

  NCT06799000· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study of Barzolvolimab in Patients With Atopic Dermatitis

  NCT06727552· Phase 2· Celldex Therapeutics· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hidradenitis suppurativa1 recruiting

Closed trials

• Recruiting

  Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

  NCT06585410· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator